Barri Blauvelt

Demonstrating Impact of Upstream Omnichannel Strategy on Downstream Results

by Barri M. Blauvelt, CEO, Innovara Upstream strategy used to be the domain of health care marketing. Today, it involves commercial, clinical research, access management,...

Barri Blauvelt - March 28, 2018

Join the Global Longevity Hackathon September 24-26, 2021

Margaretta Colangelo July 30, 2021

Merck Announces Appointment of Cristal N. Downing as Chief Communications & Public Affairs Officer

Look Who’s On the Move! July 30, 2021

UK Biomanufacturing Team to Spearhead Development of Advanced Controls to Accelerate Drug and Vaccine Manufacturing

Industry News July 30, 2021

Keystone Bio Advances a More Complete Explanation of Porphyromonas Gingivalis Toxic Virulence Factors as Major Driver of Sporadic Alzheimer’s and Chronic Inflammation

Industry News July 30, 2021

Better Therapeutics and Colorado Prevention Center Clinical Research Launch Real-World Evidence Study of Prescription Digital Therapeutic for Type 2 Diabetes

Industry News July 30, 2021

Alnylam and PeptiDream Enter into Collaboration Agreement to Discover and Develop Peptide-siRNA Conjugates for Targeted Delivery of RNAi Therapeutics to a Broader Range of...

Industry News July 30, 2021

GSK announces FDA approval for Nucala (mepolizumab) for use in adults with chronic rhinosinusitis with nasal polyps

Regulatory Affairs July 30, 2021

Lantheus Announces the First and Only FDA Cleared AI-Enabled PSMA Digital Application, aPROMISE™, Strengthening Lantheus’ Leadership in Prostate Cancer

Industry News July 30, 2021

Strategic Partnership Between Genedata and SCIEX Deepens and Accelerates Characterization of Next Generation Biotherapeutics

Industry News July 30, 2021

BeiGene Announces Positive Topline Results from Phase 3 SEQUOIA Trial Comparing BRUKINSA® (Zanubrutinib) to Bendamustine Plus Rituximab in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia

Industry News July 30, 2021

Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease...

Regulatory Affairs July 30, 2021

ENYO Pharma Announces 16 Weeks Vonafexor (EYP001) Top-Line Interim Results from Two on-going Phase 2a Studies in Chronic Hepatitis B Patients

Industry News July 30, 2021

Adaptive Phage Therapeutics Appoints Robert J. Hopkins, MD, MPH & TM, FACP, FIDSA, to Chief Medical Officer

Look Who’s On the Move! July 30, 2021

Astellas and Minovia Therapeutics Announce Strategic Collaboration for Novel Mitochondrial Cell Therapy Programs

Industry News July 30, 2021

Imago BioSciences Receives Orphan Designation From European Medicines Agency for Bomedemstat for the Treatment of Essential Thrombocythemia

Regulatory Affairs July 30, 2021

Barri Blauvelt

Recent Articles